{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Eli Lilly", "item": "https://www.patentleaderboard.com/2021/company/lilly"}, {"@type": "ListItem", "position": 4, "name": "Mohamed ElSayed Hamed Elsayed", "item": "https://www.patentleaderboard.com/2021/inventor/fl:mo_ln:elsayed-2"}]}

Home › 2021 › Eli Lilly › Mohamed ElSayed Hamed Elsayed

Mohamed ElSayed Hamed Elsayed — 1 Patent in 2021

Eli Lilly: 1 patents #25 of 188Top 15%

Fishers, IN: #31 of 93 inventorsTop 35%

Indiana: #1,178 of 3,792 inventorsTop 35%

Overall (2021): #325,489 of 548,734Top 60%

1 Patents 2021

Issued Patents 2021

Showing 1–1 of 1 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
11084861	GIP/GLP1 co-agonist compounds	Milata Mary Abraham, Jorge Alsina-Fernandez, Robert Brown, Over Cabrera, Tamer Coskun +5 more	2021-08-10	$2,040,565,000

Mohamed ElSayed Hamed Elsayed — 1 Patent in 2021

Issued Patents 2021

Patent Widget